Home Other Building Blocks 4-Chloro-N-(cis-2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide

4-Chloro-N-(cis-2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide

CAS No.:
636-54-4
Catalog Number:
AG01CB83
Molecular Formula:
C14H20ClN3O3S
Molecular Weight:
345.8449
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
500mg
≥98%
1 week
United States
$97
- +
Product Description
Catalog Number:
AG01CB83
Chemical Name:
4-Chloro-N-(cis-2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide
CAS Number:
636-54-4
Molecular Formula:
C14H20ClN3O3S
Molecular Weight:
345.8449
MDL Number:
MFCD00941495
IUPAC Name:
4-chloro-N-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-3-sulfamoylbenzamide
InChI:
InChI=1S/C14H20ClN3O3S/c1-9-4-3-5-10(2)18(9)17-14(19)11-6-7-12(15)13(8-11)22(16,20)21/h6-10H,3-5H2,1-2H3,(H,17,19)(H2,16,20,21)/t9-,10+
InChI Key:
LBXHRAWDUMTPSE-AOOOYVTPSA-N
SMILES:
C[C@@H]1CCC[C@@H](N1NC(=O)c1ccc(c(c1)S(=O)(=O)N)Cl)C
EC Number:
211-261-7
UNII:
17S83WON0I
Properties
Complexity:
498  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
345.091g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
345.842g/mol
Monoisotopic Mass:
345.091g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
101A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus. Molecules (Basel, Switzerland) 20140711
Automatic analysis of EMG during clonus. Journal of neuroscience methods 20120215
Development of a liquid chromatography tandem mass spectrometry method for simultaneous determination of eight adulterants in slimming functional foods. Journal of chromatography. A 20111021
[Simultaneous determination of five illegal drugs in weight control foods with solid phase extraction-high performance liquid chromatography]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100901
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine. The international journal of neuropsychopharmacology 20060401
Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor. Blood pressure 19970901
Changes in urinary enzyme levels following the use of antihypertensive agents in patients with essential hypertension. Cardiovascular drugs and therapy 19950601
Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group. The Medical journal of Australia 19890605
Clopamide: plasma concentrations and diuretic effect in humans. Clinical pharmacology and therapeutics 19870901
Parkinson's disease on treatment with Viskaldix. The Journal of the Royal College of General Practitioners 19840301
[Viskaldix in the treatment of arterial hypertension]. Vutreshni bolesti 19820101
Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy. Current therapeutic research, clinical and experimental 19740801
Properties